Neha Mehta-Shah, MD, MSCI, of Washington University School of Medicine in St. Louis, discusses treatment advances in lymphoma, a paradigm shift she’s seen in mantle cell lymphoma, why she is excited about bispecific antibodies in B-cell lymphoma, her hopes for the future, and more, during the 2022 American Society of Hematology Annual Meeting.